Managing Elevated LDL-C Levels to Reduce ASCVD Risk: Primary and Secondary Prevention

Leading experts provide insight on management of elevated LDL-C levels to reduce ASCVD risk in the primary care setting. Learn about guideline recommendations and treatment options, including nonstatin therapies.

Share

Program Content

No activities added yet

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by an educational grant from Novartis Pharmaceuticals Corporation.

Novartis Pharmaceuticals Corporation

Partners

Clinical Care Options, LLC

ProCE Banner